Synpromics, the leader in gene control, is delighted to announce that David Venables, CEO of the Company, has won the ‘Disruptor’ category of Scotland’s EY Entrepreneur Of The Year 2018.

David was nominated in the ‘Disruptor’ category, recognising entrepreneurs ‘with the vision and courage to challenge the status quo’ and for ‘shaping and improving our working world and constantly striving for excellence’. The judges commented "David won the disruptor category for his clever business model. With David’s vision and great strategy, the company has raised in excess of £7m since 2015, moved to new facilities to accommodate the growing number of staff, and opened operations in the U.S.”

Receiving the award, David Venables commented: “I am thrilled to receive such a prestigious award, especially when up against so many fantastic entrepreneurs contributing so much to the Scottish economy. Synpromics continues to grow and thrive, revolutionising gene control and promoter design, and I am delighted to be leading our dedicated team to furthering this goal.”

Synpromics’ technology enables unprecedented control of gene expression through its ability to custom design synthetic cell-type, or condition, specific promoters. David’s dependable leadership of the Company over the past four years has uniquely facilitated the Company’s expansion, and rightly merits this esteemed award.

EY Entrepreneur Of The Year recognises the contribution of entrepreneurs to the UK economy and this year celebrates its 20th anniversary.